Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection.,Journal of Clinical Immunology

当前位置： X-MOL 学术 › J. Clin. Immunol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection.
Journal of Clinical Immunology ( IF 9.1 ) Pub Date : 2021-08-23 , DOI: 10.1007/s10875-021-01119-y
Mathieu Paul Rodero ₁ , Stéphane Pelleau ₂ , Anne Welfringer-Morin ₃ , , Darragh Duffy ₄ , Isabelle Melki _{5,

6,

7} , Brigitte Bader-Meunier _{7,

8} ,

Affiliation

Chimie & Biologie, Modélisation et Immunologie pour la Thérapie (CBMIT), Université Paris Descartes, CNRS, UMR8601, Paris, France.
Infectious Diseases Epidemiology and Analytics Unit, Department of Global Health, Institut Pasteur, Paris, France.
Department of Dermatology, Université de Paris AP-HP-5, Necker-Enfants Malades Hospital, Paris, France.
Translational Immunology Lab, Institut, Pasteur, Paris, France.
Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Paris University, Paris, France.
General Paediatrics, Department of Infectious Disease and Internal Medicine, Reference centre for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Robert Debré, Hospital, AP-HP, |Paris, France.
Department of Paediatric Hematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP, Paris, France, Reference center for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Paris, France.
Laboratory of Immunogenetics of Paediatric Autoimmunity, Imagine Institute, Inserm U 1163, Paris University, Paris, France.